Niki BioSolutions, Inc. (NIKI) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Niki BioSolutions, Inc. (NIKI) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $561,915, listed on NASDAQ, employing roughly 1 people, carrying a beta of 0.17 to the broader market. Niki BioSolutions is a biopharmaceutical company that resulted from the merger of Aptorum Group and DiamiR Biosciences. Led by Chung Yuen Huen, public since 2026-07-20.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for NIKI as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →